The Healthcare Analytics Summit is back! Join us live in Salt Lake City, Sept. 13-15.Register Now
How Data Digitization Can Advance Life Sciences
Sadiqa Mahmood, DDS, MPH
General Manager & Senior Vice President, Life Sciences Business
Sadiqa Mahmood, General Manager and Senior Vice President of Life Sciences Business at Health Catalyst, discusses the transformation of the life sciences industry in this episode of the Health Catalyst podcast, Owning the Future of Healthcare. Mahmood explains how the pandemic forced the life sciences industry to further adopt digitization and how the digital transformation is shifting the traditional mindset of pharmaceutical and medical technology companies from site centric to patient centric.
Tune in to Hear Mahmood Answer These Questions
- Which organizations within the healthcare sector did COVID-19 impact the most? 2:39
- How did COVID-19 impact the life sciences sector? 2:50
- How did the pandemic accelerate the timeline for drugs and vaccines? 5:20
- 我们在哪些地方看到了数据和分析加速药物开发过程的未实现的机会?11:23
- How can industry professionals maximize existing data to derive more insights and increase efficiencies within drug development? 15:15
- 生命科学组织或医疗技术公司如何获取用于药物开发过程的准确数据?16:15
Noteworthy Quotes from Mahmood
“Navigating the ongoing COVID-19 pandemic has been an all-encompassing, once-in-a-lifetime experience for the life sciences industry.”
“The industry transitioned from being site centric to being patient centric in research, due to digitization.”
“To inform drug development, data has to be representative of the populations you serve.”
“While eight-and-a-half-years is the average time frame for new drug development, the two novel COVID-19 vaccines were developed, tested, and authorized in less than a year.”
This site uses cookies
We take pride in providing you with relevant, useful content. May we use cookies to track what you read? We take your privacy very seriously. Please see ourprivacy policy详情和任何问题。